IHA Hematology Oncology Consultants

Recent papers from IHA Hematology Oncology Consultants

1. Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801)Journal of Clinical Oncology · 2026
2. Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2Journal of Clinical Oncology · 2026
3. A phase 2 randomized trial of radium-223 dichloride and cabozantinib in patients (pts) with renal cell carcinoma (RCC) with bone metastases (BM): RADICAL (Alliance A031801).Journal of Clinical Oncology · 2026
4. Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0Journal of Clinical Oncology · 2026
5. Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0Journal of Clinical Oncology · 2026
6. Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1Journal of Clinical Oncology · 2025
7. Breast Biomarker Cytology Practice in 2023: Results of a College of American Pathologists SurveyArchives of Pathology & Laboratory Medicine · 2025
8. A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutationsESMO Open · 2024
9. Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3Journal of Clinical Oncology · 2024
10. Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3Journal of Clinical Oncology · 2024
11. Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapiesBlood Advances · 2023
12. PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048).Journal of Clinical Oncology · 2023
13. Preoperative Treatment of Locally Advanced Rectal CancerNew England Journal of Medicine · 2023
14. Disparities in melanoma incidence and mortality in rural versus urban MichiganCancer Reports · 2022
15. Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non–Small-Cell Lung Cancer Previously Treated With Immunotherapy—Lung-MAP S1800AJournal of Clinical Oncology · 2022
16. P1156: Magnify Phase 3b Study of Lenalidomide + Rituximab (R2) Followed by Maintenance in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: Complete Induction Phase AnalysisHemaSphere · 2022
17. Positron Emission Tomography–Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001Journal of Clinical Oncology · 2020
18. A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine TumorsClinical Cancer Research · 2020
19. The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromesLeukemia & lymphoma/Leukemia and lymphoma · 2019
20. Impact of Behavioral Feeding Intervention on Child Emotional and Behavioral Functioning, Parenting Stress, and Parent‐Child AttachmentJournal of Pediatric Gastroenterology and Nutrition · 2019